T. Rowe Price - Home
Choose your site Enterprise Personal Investing Workplace Retirement Institutional Investors/Consultants Financial Intermediary Retirement Plan Sponsors / Consultants Oak Hill Advisors, L.P. (OHA) – External Site
Your location and language
English
Choose your site Enterprise Personal Investing Workplace Retirement Institutional Investors/Consultants Financial Intermediary Retirement Plan Sponsors / Consultants Oak Hill Advisors, L.P. (OHA) – External Site
Your location and language
English
Your location and language
English
View Supported Browsers
Headshot of Georgi Yordanov

Georgi Yordanov,

Ph.D.

Investment Analyst
About

Georgi Yordanov is an investment analyst in health care, covering small- and mid-cap biotech stocks, in the U.S. Equity Division of T. Rowe Price Investment Management.

Education
  • Ph.D., Watson School of Biological Sciences, Cold Spring Harbor Laboratory
  • B.Sc., honors, University of Liverpool
At a glance
Years at T. Rowe Price
3
Years of investment experience
7
Latest Insights
View more insights

4535800

Download

Latest Date Range
Audience for the document: Share Class: Language of the document:
Download Cancel

Open

Share Class: Language of the document:
Open Cancel
Sign in to manage subscriptions for products, insights and email updates.
Sign in
Once registered, you'll be able to start subscribing.
Continue Back

Change Details

If you need to change your email address please contact us.
Change password
Save Cancel
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price (“TRP”) claims compliance with the Global Investment Performance Standards (GIPS®).

A complete list and description of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request. 

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest